AR039221A1 - Combinaciones de epinastina, belladona y pseudoefedrina como formulaciones farmaceuticas - Google Patents

Combinaciones de epinastina, belladona y pseudoefedrina como formulaciones farmaceuticas

Info

Publication number
AR039221A1
AR039221A1 ARP030101144A ARP030101144A AR039221A1 AR 039221 A1 AR039221 A1 AR 039221A1 AR P030101144 A ARP030101144 A AR P030101144A AR P030101144 A ARP030101144 A AR P030101144A AR 039221 A1 AR039221 A1 AR 039221A1
Authority
AR
Argentina
Prior art keywords
pharmaceutically acceptable
epinastine
amount
acceptable salt
belladonna
Prior art date
Application number
ARP030101144A
Other languages
English (en)
Spanish (es)
Inventor
Noritaka Seko
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AR039221A1 publication Critical patent/AR039221A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP030101144A 2002-04-03 2003-04-02 Combinaciones de epinastina, belladona y pseudoefedrina como formulaciones farmaceuticas AR039221A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02007568A EP1350512A1 (en) 2002-04-03 2002-04-03 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations

Publications (1)

Publication Number Publication Date
AR039221A1 true AR039221A1 (es) 2005-02-09

Family

ID=27838061

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101144A AR039221A1 (es) 2002-04-03 2003-04-02 Combinaciones de epinastina, belladona y pseudoefedrina como formulaciones farmaceuticas

Country Status (12)

Country Link
US (1) US20030228359A1 (cg-RX-API-DMAC7.html)
EP (2) EP1350512A1 (cg-RX-API-DMAC7.html)
JP (1) JP2005522467A (cg-RX-API-DMAC7.html)
AR (1) AR039221A1 (cg-RX-API-DMAC7.html)
AU (1) AU2003221532A1 (cg-RX-API-DMAC7.html)
BR (1) BR0308982A (cg-RX-API-DMAC7.html)
CA (1) CA2477751A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04009582A (cg-RX-API-DMAC7.html)
PE (1) PE20040080A1 (cg-RX-API-DMAC7.html)
PL (1) PL371382A1 (cg-RX-API-DMAC7.html)
RU (1) RU2004132205A (cg-RX-API-DMAC7.html)
WO (1) WO2003082285A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
JP2007517766A (ja) * 2003-09-24 2007-07-05 コンビナトアールエックス インコーポレーティッド 薬物の組み合わせを投与するための治療法
AU2005210086A1 (en) * 2004-02-06 2005-08-18 Meda Pharma Gmbh & Co. Kg Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
JP4936420B2 (ja) * 2005-08-02 2012-05-23 塩野義製薬株式会社 徐放性顆粒剤
JP5162141B2 (ja) * 2007-02-20 2013-03-13 エスエス製薬株式会社 フィルムコーティング用組成物
RU2366446C1 (ru) * 2008-06-27 2009-09-10 Сергей Анатольевич Небера Гомеопатическое средство для лечения конъюнктивитов
WO2010030418A1 (en) * 2008-09-10 2010-03-18 Micro-Dose Life Sciences Llc Anti-fever botanical composition and uses thereof
RU2567032C2 (ru) * 2009-05-01 2015-10-27 Апталис Фарматек, Инк. Перорально распадающиеся таблеточные композиции, содержащие комбинации неопиоидных и опиоидных анальгетиков
JP5852816B2 (ja) * 2010-09-10 2016-02-03 ロート製薬株式会社 液状医薬組成物、及びこれを含有する軟カプセル剤
RU2478377C1 (ru) * 2011-08-08 2013-04-10 Алексей Владимирович Брынцалов Комбинированный препарат орвиум для устранения симптомов простудных заболеваний и гриппа
CN110237079B (zh) * 2019-07-01 2021-05-14 山西大学 一种百部生物碱类似物的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10298107A (ja) * 1997-04-25 1998-11-10 Taisho Pharmaceut Co Ltd 医薬組成物
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist

Also Published As

Publication number Publication date
EP1350512A1 (en) 2003-10-08
PE20040080A1 (es) 2004-04-22
CA2477751A1 (en) 2003-10-09
PL371382A1 (en) 2005-06-13
AU2003221532A1 (en) 2003-10-13
MXPA04009582A (es) 2005-01-11
RU2004132205A (ru) 2005-09-10
US20030228359A1 (en) 2003-12-11
WO2003082285A1 (en) 2003-10-09
BR0308982A (pt) 2005-01-04
JP2005522467A (ja) 2005-07-28
EP1492532A1 (en) 2005-01-05

Similar Documents

Publication Publication Date Title
PY0228832A (es) Formulaciones farmaceuticas de 5,7,14-triazatetra-ciclo [10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaeno
ES2160648T3 (es) Derivados de piridina.
ECSP088404A (es) Nuevos derivados de imidazo[4,5-b]piridina como inhibidores de la glucógeno sintasa quinasa 3, para uso en el tratamiento de demencia y trastornos neurodegenerativos
ES2733044T1 (es) Composición farmacéutica que contiene oxicodona y naloxona
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ES2076935T3 (es) Compuesto de pirazolopiridina y procedimientos para su preparacion.
AR030190A1 (es) Una pirimidinona o una sal farmaceuticamente aceptable de la misma, composicion farmaceutica que la comprende, uso de dicho compuesto en la fabricacion de medicamentos y procedimiento para prepararlo
BRPI0413393A (pt) fexofenadina, composição farmaceuticamente aceitável, método de tratamento antihistamìnico, composição, processo para preparar fexofenadina e uso de fexofenadina
CO4950524A1 (es) Inhibidores de acido nitrico sintasa
US6469009B1 (en) Pharmaceutical compositions for the treatment of rhinitis
PE20040080A1 (es) Combinaciones de epinastina, belladona y pseudoefefrina como nuevas formulaciones farmaceuticas
CL2024003616A1 (es) Composición farmacéutica oral y uso para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas.
JP2025507472A5 (cg-RX-API-DMAC7.html)
AR087240A2 (es) Composiciones farmaceuticas que tienen epinastina y pseudoefedrina
AR018505A1 (es) COMPOSICIoN FARMACÉUTICA ANTIHISTAMíNICA CON UN INHIBIDOR DE LA P-GLICOPROTEíNA Y EL USO DE DICHA COMPOSICIoN PARA LA FABRICACIoN DE MEDICAMENTOS PARA AUMENTAR LA BIODISPONIBILIDAD DE DICHO ANTIHISTAMíNICO.
MX9205123A (es) Derivados de 5-hidroxi-2-pirimidinilmetileno utiles como agentes anti-inflamatorios.
UY28979A1 (es) Derivados de hidrocloruros de 3-carboxamida, composiciones farmacéuticas que los contienen, procedimiento de preparación y su uso, útiles como inhibidores selectivos de gsk3
ES2115571T3 (es) Uso de polisulfato de pentosana para la resolucion de cicatrices en enfermedades vasculares progresivas cronicas.
UY29823A1 (es) Derivados sustituidos de 7-cloro-3h-imidazol-(4,5-b) piridina, composiciones farmacéuticas que los contienen, procesos para la preparación de los mismos y aplicaciones
AR037496A1 (es) Uso novedoso del 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano y sus sales fisiologicamente aceptables
AR040764A1 (es) Formulaciones farmaceuticas de epinastina, pseudoefedrina y metilefedrina
UY27747A1 (es) Combinaciones de epinastina, belladona y pseudoefedrina como nuevas formulaciones farmacéuticas.
UY27001A1 (es) Derivados de la indolilpiperidina como agentes antihistamínicos y antialérgicos
RU2005100846A (ru) Фармацевтические соли ребоксетина
PA8579701A1 (es) Profarmaco inhibidor de beta-lactamasa

Legal Events

Date Code Title Description
FB Suspension of granting procedure